No Detail Found!

Rofound hearing impairment in patients -^ith chronic hepatitis c treated with “nterferon alpha-2b

Author(s)
Ahfaq Ahmed Gastroenterology Section, Aga Khan University Hospital, Karachi, Pakistan.
Abdul Haleem Khan Gastroenterology Section, Aga Khan University Hospital, Karachi, Pakistan.
Shahab Abid Gastroenterology Section, Aga Khan University Hospital, Karachi, Pakistan.
Zaigam Abbas Gastroenterology Section, Aga Khan University Hospital, Karachi, Pakistan.
Abdulla Ahssiri King Faisal Specialists Hospital and Research Centre, Jeddah, Saudi Arabia.
Abstract
Alpha interferon is the approved agent for treatment of hepatitis C. Its use is becoming common and with this increase in its use new side effects are being observed. These side effects should be identified early and one should be familiar with their course and outcome. The knowledge of the incidence, severity and reversibility of these side effects would impact on the treatment strategy. We are reporting three cases of recombinant alpha interferon related hearing impairment.The severity of deafness varied from moderate to severe, and with discontinuation of therapy the improvement was unpredictable. In some patients there was marked improvement while in others there was little or no improvement. .
Publication Details
Page(s) 773-775
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 11, Issue: 12, Year: 2001

Request the full text from PASTIC

Keywords
deafness, hepatitis C, Antiviral Agents
References
QuesadaJR .1986 .Clinicatloxicityofinterferoninscancerpatientsa: review. JCtinOnco!, 4 : 234-43.
Brouty-BoyD .1980 .. Inhibitionofcellmotilityby interferoSnc.ience, 208 : 516-8.
. .. AM BisceglineNEJM, Jan, 30(Volume336) : 347-56.
.1997 .. Interferoanlphain thetreatmeonft chronicviralhepatitisB andC. DIOR, 31 : 330-7.
0

Citations

0

Downloads

58

Views